PETS 📈 PetMed Express - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7163821066
PETS: Pet Medications, Health Products, Pet Supplies, Food, Beds, Crates
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida. Web URL: https://www.1800petmeds.com
Additional Sources for PETS Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PETS Stock Overview
Market Cap in USD | 96m |
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
GiC Sub-Industry | Other Specialty Retail |
IPO / Inception | 1999-04-26 |
PETS Stock Ratings
Growth 5y | -86.8% |
Fundamental | -20.8% |
Dividend | 26.3% |
Rel. Strength Industry | -220 |
Analysts | 2/5 |
Fair Price Momentum | 4.88 USD |
Fair Price DCF | - |
PETS Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 94.7% |
PETS Growth Ratios
Growth Correlation 3m | 88.8% |
Growth Correlation 12m | -48.5% |
Growth Correlation 5y | -90.5% |
CAGR 5y | -23.80% |
CAGR/Mean DD 5y | -0.45 |
Sharpe Ratio 12m | -0.38 |
Alpha | -50.49 |
Beta | 0.56 |
Volatility | 50.46% |
Current Volume | 544.2k |
Average Volume 20d | 324.5k |
What is the price of PETS stocks?
As of December 22, 2024, the stock is trading at USD 4.97 with a total of 544,170 shares traded.
Over the past week, the price has changed by -10.53%, over one month by +12.58%, over three months by +34.92% and over the past year by -32.09%.
As of December 22, 2024, the stock is trading at USD 4.97 with a total of 544,170 shares traded.
Over the past week, the price has changed by -10.53%, over one month by +12.58%, over three months by +34.92% and over the past year by -32.09%.
Is PetMed Express a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, PetMed Express is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PETS as of December 2024 is 4.88. This means that PETS is currently overvalued and has a potential downside of -1.81%.
Neither. Based on ValueRay Fundamental Analyses, PetMed Express is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -20.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PETS as of December 2024 is 4.88. This means that PETS is currently overvalued and has a potential downside of -1.81%.
Is PETS a buy, sell or hold?
PetMed Express has received a consensus analysts rating of 2.00. Therefor, it is recommend to sell PETS.
PetMed Express has received a consensus analysts rating of 2.00. Therefor, it is recommend to sell PETS.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecast for PETS stock price target?
According to ValueRays Forecast Model, PETS PetMed Express will be worth about 5.4 in December 2025. The stock is currently trading at 4.97. This means that the stock has a potential upside of +7.65%.
According to ValueRays Forecast Model, PETS PetMed Express will be worth about 5.4 in December 2025. The stock is currently trading at 4.97. This means that the stock has a potential upside of +7.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3.8 | -24.5% |
Analysts Target Price | 15 | 201.8% |
ValueRay Target Price | 5.4 | 7.6% |